Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGI
2776
DELISTED
Triumph Group
TGI
| $2.23M | ﹤0.01% |
134,444
+85,899
| +177% | +$871K |
|
|
HOLX
2777
CALL
DELISTED
Hologic
HOLX
| $2.22M | ﹤0.01% |
+31,100
| New | +$2.17M |
|
|
DMC
2778
Del Monte Corp
DMC
$1.43B
| $2.22M | ﹤0.01% |
84,575
+40,477
| +92% | +$997K |
|
2779
PUT
Healthpeak Properties
DOC
$14.5B
| $2.22M | ﹤0.01% |
+112,000
| New | +$1.97M |
|
2780
CALL
Elevance Health
ELV
$85.8B
| $2.22M | ﹤0.01% |
4,700
-4,700
| -50% | -$2.17M |
|
|
2781
PUT
Elevance Health
ELV
$85.8B
| $2.22M | ﹤0.01% |
4,700
-4,700
| -50% | -$2.17M |
|
2782
SunCoke Energy
SXC
$800M
| $2.21M | ﹤0.01% |
206,171
-194,613
| -49% | -$1.86M |
|
|
PGRE
2783
DELISTED
Paramount Group
PGRE
| $2.21M | ﹤0.01% |
428,214
+223,046
| +109% | +$1.06M |
|
|
RCM
2784
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.21M | ﹤0.01% |
209,388
-117,345
| -36% | -$1.33M |
|
2785
Victory Capital Holdings
VCTR
$6.78B
| $2.21M | ﹤0.01% |
64,247
+26,688
| +71% | +$854K |
|
2786
Northwest Natural Holdings
NWN
$2.11B
| $2.21M | ﹤0.01% |
56,742
+39,206
| +224% | +$1.49M |
|
2787
Warby Parker
WRBY
$3.24B
| $2.21M | ﹤0.01% |
156,464
+97,424
| +165% | +$1.21M |
|
2788
4D Molecular Therapeutics
FDMT
$580M
| $2.2M | ﹤0.01% |
108,709
+34,774
| +47% | +$458K |
|
2789
PUT
Core & Main
CNM
$8.62B
| $2.2M | ﹤0.01% |
+54,500
| New | +$1.84M |
|
2790
PUT
Intellia Therapeutics
NTLA
$1.69B
| $2.2M | ﹤0.01% |
+72,200
| New | +$2.08M |
|
2791
Palomar
PLMR
$3.44B
| $2.2M | ﹤0.01% |
39,658
+24,599
| +163% | +$1.38M |
|
|
JOYY
2792
JOYY Inc
JOYY
$3.77B
| $2.2M | ﹤0.01% |
55,424
+2,274
| +4% | +$90.4K |
|
2793
Alphatec Holdings
ATEC
$1.47B
| $2.2M | ﹤0.01% |
145,301
+117,098
| +415% | +$1.4M |
|
2794
Monarch Casino & Resort
MCRI
$2.16B
| $2.19M | ﹤0.01% |
31,650
+14,355
| +83% | +$914K |
|
2795
Urban One Class D
UONEK
$23.1M
| $2.19M | ﹤0.01% |
61,935
-11,195
| -15% | -$512K |
|
2796
BCE
BCE
$21B
| $2.19M | ﹤0.01% |
55,492
+5,168
| +10% | +$200K |
|
2797
Ascendis Pharma A/S
ASND
$16.7B
| $2.18M | ﹤0.01% |
17,325
-157
| -0.9% | -$15.7K |
|
2798
US Physical Therapy
USPH
$1.22B
| $2.18M | ﹤0.01% |
23,425
+16,371
| +232% | +$1.44M |
|
2799
CALL
eBay
EBAY
$47.9B
| $2.18M | ﹤0.01% |
50,000
-50,000
| -50% | -$2.07M |
|
|
ZPTAW
2800
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
| $2.18M | ﹤0.01% |
200,000
| – | – |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.